[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349098-105":59,"doc-detail-349098-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","designing-a-novel-immunotoxin-against-prostate-cancer-based-on-pe40-toxin-an-in-silico-approach","Designing a Novel Immunotoxin against Prostate Cancer based on PE40 Toxin - An In silico Approach","","Prostate cancer remains a major malignancy and a leading cause of cancer-related death among men, with limited efficacy and troubling adverse effects from conventional therapies. Cancer-targeted immunotoxins are explored as fusion agents that recognize tumor antigens and induce cell death. The work designs a novel immunotoxin by combining a prostate-specific scFv with a truncated Pseudomonas-exotoxin and evaluates structure, stability, docking, and molecular dynamics performance to support candidate selection for future experiments.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/designing-a-novel-immunotoxin-against-prostate-cancer-based-on-pe40-toxin-an-in-silico-approach/349098/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/designing-a-novel-immunotoxin-against-prostate-cancer-based-on-pe40-toxin-an-in-silico-approach/349098.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main therapeutic concept used in this study?","Question",{"text":112,"@type":113},"The study uses cancer-targeted immunotoxins that fuse a targeting molecule with a toxin to recognize a prostate cancer antigen and trigger cell death.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which biological components are combined to construct the novel immunotoxin?",{"text":117,"@type":113},"It combines a prostate-specific scFv with a truncated version of Pseudomonas-exotoxin.",{"name":119,"@type":110,"acceptedAnswer":120},"What computational steps are used to evaluate the designed immunotoxin structure?",{"text":121,"@type":113},"Secondary structure and physicochemical properties are predicted using SOPMA, Protparam, and AllergenFP, 3D modeling is built using ITASSER, validation uses ProSa-web and PROCHECK, docking uses Cluspro, and molecular dynamics is run with GROMACS.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349098,1790468003,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Designing a Novel Immunotoxin against Prostate Cancer based on PE40 Toxin: An In silico Approach  \nSadaf Azdoo 1, Mortaza Taheri-Anganeh 2, Khadijeh Ahmadi 3, Abdolkarim Ghadimi Moghadam 4,  \nAhmad Movahedpour 1􀀍 and Ali Jamshidi 5􀀍  \n1. Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran  \n2. Cellular and Molecular Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran  \n3. Department of Medical Biotechnology, School of Paramedicine, Bushehr University of Medical Sciences, Bushehr, Iran  \n4. Pediatric Infectious Ward, Yasuj University of Medical Sciences, Yasuj, Iran  \n5. Behbahan Faculty of Medical Sciences, Behbahan, Iran  \n* Corresponding authors: Ahmad Movahedpour, Ph.D., Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran  \nAli Jamshidi, Ph.D., Behbahan Faculty of Medical Sciences, Behbahan, Iran  \nTel: +98 74 33346078  \nE-mail: [ahmad.movahed14@gmail.com](ahmad.movahed14@gmail.com), [dani1364@gmail.com](dani1364@gmail.com)[ ](dani1364@gmail.com)[Received:](Received: 16 Jul 2025)[ 16 Jul 2025](Received: 16 Jul 2025)  \n[Accepted](Accepted: 29 Nov 2025)[: 29 Nov 2025](Accepted: 29 Nov 2025)  \nAbstract  \nBackground: Prostate cancer, is the second most prevalent malignant tumor and fifth leading cause of cancer-related death among men worldwide. Patients suffer from adverse side effects and low efficacy of traditional therapeutic approaches. At present, cancer-targeted therapy is a fascinating strategy of cancer therapy re-search via employing immunotoxins, which is a fusion of a targeting molecule and a killer toxin that can recognize a specific antigen on cancerous cells and trigger cell death.  \nMethods: This study used a prostate-specific scFv and a truncated version of Pseudomonas-exotoxin to design a novel immunotoxin. After the construct design, the construct's secondary structure, physicochemical features, and allergenicity were predicted by SOPMA, Protparam, and AllergenFP, respectively. Then, the 3D structure was built via ITASSER. ProSa-web and PROCHECK were used for structure validation. The 3D model was docked by Cluspro, and molecular dynamics was carried out by GROMACS.  \nResults: The results showed that the average RMSF value for the PSMA receptor was 0.478 Å, and for the designed toxin was 0.292 Å . The low range of changes in-dicates the stability of the complex during the simulation.  \nConclusion: The present results indicate that the designed immunotoxin is structurally stable, non-allergenic, and capable of binding PSMA, suggesting it as a potential candidate for further experimental evaluation.  \nKeywords: Allergens, Cell, Death, Immunotoxins, Molecular dynamics simulation, Prostate, Prostatic neoplasms, Pseudomonas  \nTo cite this article: Azdoo S, Taheri-Anganeh M, Ahmadi Kh, Ghadimi-Moghadam A, Movahedpour A, Jamshidi A. Designing a Novel Immunotoxin against Prostate Cancer based on PE40 Toxin: An In silico Approach. Avicenna J Med Biotech 2026; 18(1):69-78.  \nIntroduction  \nProstate Cancer (PCa) is the second most prevalent malignant tumor in men and the fifth leading cause of death worldwide 1. Although surgery or radiation therapy can successfully treat primary PCa, 18% of PCa patients in advanced stages die every year due to a lack of curative treatments 2,3 . Therefore, the development of new molecular-targeted therapy methods seems as necessary as possible 4,5 . A number of tumor cell components, such as glycoproteins or cell surface proteins  \nthat function as enzymes or receptors, are therapeutic targets for PCa treatment. The Prostate-Specific Membrane Antigen (PSMA) is commonly utilized as a therapeutic target for the generation of immunotoxin against PCa due to its constitutive or induced internalization property 6-8.  \nThe PSMA as a type II membrane-glycoprotein with a molecular weight of 100 kDa is recognized as glutamate carboxypeptidase II or folate","cbCaideWMmg6SEIa","https://ap.wps.com/l/cbCaideWMmg6SEIa","pdf",834304,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the main therapeutic concept used in this study?\",\"answer\":\"The study uses cancer-targeted immunotoxins that fuse a targeting molecule with a toxin to recognize a prostate cancer antigen and trigger cell death.\"},{\"question\":\"Which biological components are combined to construct the novel immunotoxin?\",\"answer\":\"It combines a prostate-specific scFv with a truncated version of Pseudomonas-exotoxin.\"},{\"question\":\"What computational steps are used to evaluate the designed immunotoxin structure?\",\"answer\":\"Secondary structure and physicochemical properties are predicted using SOPMA, Protparam, and AllergenFP, 3D modeling is built using ITASSER, validation uses ProSa-web and PROCHECK, docking uses Cluspro, and molecular dynamics is run with GROMACS.\"}]","Designing a Novel Immunotoxin against Prostate Cancer based on PE40 Toxin - An In silico Approach | PDF",1790081615,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/539adad2fe5c0ec4abdc3149e4f3d268.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/150647a9c3b17e7f0b9897dcce5d706a.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee288a47b3950c3741831236c45735ff.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07e00f3c404a502233917bf62ec8324b.webp",980,1385]